Treatment and management of multiple sclerosis.
D000998:Antiviral Agents / Q000627:therapeutic use; D003711:Demyelinating Diseases / Q000188:drug therapy; D005983:Glutens; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008041:Linoleic Acids / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000178:diet therapy / Q000534:rehabilitation / Q000628:therapy*; D010166:Palliative Care; D014165:Transfer Factor / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D008041:Linoleic Acids; D014165:Transfer Factor; D005983:Glutens; D014805:Vitamin B 12